Fig. 7

General landscape of the effectiveness of the potential predictive therapeutic drugs. (A) Lollipop diagram exhibited the correlated relationship between the CDI and the IC50 of several predictive drugs. (B–O) The IC50 of (B) Acetalax, (C) Afatinib, (D) AZD8186, (E) Ipatasertib, (F) Alpelisib, (G) AZD1332, (H) AZD5582, (I) JQ1, (J) Sabutoclax, (K) AZD8055, (L) AZD8055 (M) Sinularin, (N) Tasclisib, (O) Tramctinib and (P) Uprosertib between the high- and low-CDI group.